Continued effect of intermittent subcutaneous apomorphine following long-term use in patients with advanced Parkinson's disease

被引：0
|
作者：
Pfeiffer, DF
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P814
引用
收藏
页码：S281 / S282
页数：2
相关论文
共 50 条
  • [1] Intermittent subcutaneous apomorphine in advanced Parkinson's disease
    Storch, A
    PSYCHOPHARMAKOTHERAPIE, 2005, 12 (01): : 17 - 22
  • [2] The tolerability of intermittent subcutaneous apomorphine in patients with advanced Parkinson's disease
    Koller, D
    Pahwa, D
    MOVEMENT DISORDERS, 2004, 19 : S203 - S203
  • [3] Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
    Pfeiffer, Ronald F.
    Gutmann, Ludwig
    Hull, Keith L., Jr.
    Bottini, Peter B.
    Sherry, James H.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (02) : 93 - 100
  • [4] Subcutaneous apomorphine injections for advanced Parkinson's disease: a long-term follow-up
    Athanasopoulos, D.
    Tagaris, G. A.
    Karageorgiou, C. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 655 - 655
  • [5] The long-term effect of continuous subcutaneous apomorphine infusions on camptocormia in Parkinson's disease
    Mensikova, Katerina
    Kaiserova, Michaela
    Vastik, Miroslav
    Nevrly, Martin
    Kurcova, Sandra
    Kanovsky, Petr
    Colosimo, Carlo
    PARKINSONISM & RELATED DISORDERS, 2020, 75 : 14 - 16
  • [6] Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
    Stocchi, F
    Vacca, L
    De Pandis, MF
    Barbato, L
    Valente, M
    Ruggieri, S
    NEUROLOGICAL SCIENCES, 2001, 22 (01) : 93 - 94
  • [7] Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
    F. Stocchi
    L. Vacca
    M. F. De Pandis
    L. Barbato
    M. Valente
    S. Ruggieri
    Neurological Sciences, 2001, 22 : 93 - 94
  • [8] Decrease in UPDRS motor scores following intermittent subcutaneous apomorphine for 6 months in patients with advanced Parkinson's disease
    Trosch, DM
    MOVEMENT DISORDERS, 2004, 19 : S217 - S217
  • [9] Safety following a single subcutaneous injection of apomorphine in patients with advanced Parkinson's disease
    Gutmann, D
    MOVEMENT DISORDERS, 2004, 19 : S273 - S273
  • [10] Cognitive Effects of Long-term Treatment with Waking-hour Subcutaneous Apomorphine Infusions in Patients with Advanced Parkinson's Disease
    Kubikova, R.
    Tyrlik, M.
    Rektorova, I.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2011, 74 (04) : 463 - 466
12345